The EMHA worked along KPMG on a market research to understand the patient journey and burden of disease for migraine in 12 countries. The Access to care survey 2021 has shown insightful results on the patients’ access to treatment and care in each of their country. Summary of the “Access To Care III” survey results

In 2018 EMHA organised a survey among migraine patients working in 7 EU countries (Ireland, Italy, France, Germany, Portugal, Spain and United Kingdom.
The survey shed light on how women have to juggle between migraine attacks and work.

After launching The Migraine Movement Manifesto, from EMHA, we set the goal to inform the largest amount of European migraine sufferers about the existence of that movement, born with the aim of giving them visibility, answers and support.

We realized that the words we normally use to describe our relationship with migraine simply fall short to convey the true feeling behind. Words like “pain” or “horror”, commonly used to describe a migraine, ended up being generic adjectives that linked our disease to a simple headache.

The lack of medical training is the main barrier for an accurate diagnosis when a possible migraine patient first visits a doctor. In the world, only 4 hours of migraine are studied in medical training.

The objective of this study is to know the situation of migraine workers within the workplace and compare the situation in the different participating countries.
European survey.